These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 33742471)
1. Metabolic study of ginsenoside Rg3 and glimepiride in type 2 diabetic rats by liquid chromatography coupled with quadrupole-Orbitrap mass spectrometry. Yang D; Li X; Fu Y; Tao X; Zheng F; Yu J; Yue H; Dai Y Rapid Commun Mass Spectrom; 2021 Jun; 35(11):e9083. PubMed ID: 33742471 [TBL] [Abstract][Full Text] [Related]
2. UHPLC-MS-Based Serum and Urine Metabolomics Reveals the Anti-Diabetic Mechanism of Ginsenoside Re in Type 2 Diabetic Rats. Wang H; Teng Y; Li S; Li Y; Li H; Jiao L; Wu W Molecules; 2021 Nov; 26(21):. PubMed ID: 34771066 [No Abstract] [Full Text] [Related]
3. Stereoselective pharmacokinetic and metabolism studies of 20(S)- and 20(R)-ginsenoside Rg₃ epimers in rat plasma by liquid chromatography-electrospray ionization mass spectrometry. Peng M; Li X; Zhang T; Ding Y; Yi Y; Le J; Yang Y; Chen X J Pharm Biomed Anal; 2016 Mar; 121():215-224. PubMed ID: 26826673 [TBL] [Abstract][Full Text] [Related]
4. Effect of 20(S)-ginsenoside Rg3 on streptozotocin-induced experimental type 2 diabetic rats: a urinary metabonomics study by rapid-resolution liquid chromatography/mass spectrometry. Niu J; Pi ZF; Yue H; Yang H; Wang Y; Yu Q; Liu SY Rapid Commun Mass Spectrom; 2012 Dec; 26(23):2683-9. PubMed ID: 23124658 [TBL] [Abstract][Full Text] [Related]
5. Stereoselective determination of ginsenosides Rg3 and Rh2 epimers in rat plasma by LC-MS/MS: application to a pharmacokinetic study. Bae SH; Zheng YF; Yoo YH; Kim JY; Kim SO; Jang MJ; Seo JH; Bae SK J Sep Sci; 2013 Jun; 36(12):1904-12. PubMed ID: 23559579 [TBL] [Abstract][Full Text] [Related]
6. In vitro studies on the oxidative metabolism of 20(s)-ginsenoside Rh2 in human, monkey, dog, rat, and mouse liver microsomes, and human liver s9. Li L; Chen X; Zhou J; Zhong D Drug Metab Dispos; 2012 Oct; 40(10):2041-53. PubMed ID: 22829543 [TBL] [Abstract][Full Text] [Related]
7. High performance liquid chromatographic-mass spectrometric determination of ginsenoside Rg3 and its metabolites in rat plasma using solid-phase extraction for pharmacokinetic studies. Xie HT; Wang GJ; Sun JG; Tucker I; Zhao XC; Xie YY; Li H; Jiang XL; Wang R; Xu MJ; Wang W J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(2):167-73. PubMed ID: 15734156 [TBL] [Abstract][Full Text] [Related]
8. In Vitro/In Vivo Metabolism of Ginsenoside Rg5 in Rat Using Ultra-Performance Liquid Chromatography/Quadrupole-Time-of-Flight Mass Spectrometry. Hong C; Yang P; Li S; Guo Y; Wang D; Wang J Molecules; 2018 Aug; 23(9):. PubMed ID: 30135411 [No Abstract] [Full Text] [Related]
9. Metabolism of 20(S)-Ginsenoside Rg₂ by Rat Liver Microsomes: Bioactivation to SIRT1-Activating Metabolites. Ma LY; Zhou QL; Yang XB; Wang HP; Yang XW Molecules; 2016 Jun; 21(6):. PubMed ID: 27294899 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous quantification of twenty-one ginsenosides and their three aglycones in rat plasma by a developed UFLC-MS/MS assay: Application to a pharmacokinetic study of red ginseng. Zhou QL; Zhu DN; Yang YF; Xu W; Yang XW J Pharm Biomed Anal; 2017 Apr; 137():1-12. PubMed ID: 28086165 [TBL] [Abstract][Full Text] [Related]
11. In vivo metabolism study of ginsenoside Re in rat using high-performance liquid chromatography coupled with tandem mass spectrometry. Yang L; Xu S; Liu C; Su Z Anal Bioanal Chem; 2009 Nov; 395(5):1441-51. PubMed ID: 19774367 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and bioavailability study of ginsenoside Rk1 in rat by liquid chromatography/electrospray ionization tandem mass spectrometry. Li J; Zhang Y; Fan A; Li G; Liu Q Biomed Chromatogr; 2019 Sep; 33(9):e4580. PubMed ID: 31077415 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous Determination of Eight Ginsenosides in Rat Plasma by Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry: Application to Their Pharmacokinetics. Ma LY; Zhang YB; Zhou QL; Yang YF; Yang XW Molecules; 2015 Dec; 20(12):21597-608. PubMed ID: 26633350 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the in vitro/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition. Zheng YF; Bae SH; Choi EJ; Park JB; Kim SO; Jang MJ; Park GH; Shin WG; Oh E; Bae SK Food Chem Toxicol; 2014 Jun; 68():117-27. PubMed ID: 24632066 [TBL] [Abstract][Full Text] [Related]
15. Comparative analysis on microbial and rat metabolism of ginsenoside Rb1 by high-performance liquid chromatography coupled with tandem mass spectrometry. Chen G; Yang M; Song Y; Lu Z; Zhang J; Huang H; Guan S; Wu L; Guo DA Biomed Chromatogr; 2008 Jul; 22(7):779-85. PubMed ID: 18384066 [TBL] [Abstract][Full Text] [Related]
16. Metabolism of sanguinarine in human and in rat: characterization of oxidative metabolites produced by human CYP1A1 and CYP1A2 and rat liver microsomes using liquid chromatography-tandem mass spectrometry. Deroussent A; Ré M; Hoellinger H; Cresteil T J Pharm Biomed Anal; 2010 Jul; 52(3):391-7. PubMed ID: 19804952 [TBL] [Abstract][Full Text] [Related]
17. Serum metabolomic analysis of the anti-diabetic effect of Ginseng berry in type II diabetic rats based on ultra high-performance liquid chromatography-high resolution mass spectrometry. Wang H; Huang R; Li H; Jiao L; Liu S; Wu W J Pharm Biomed Anal; 2021 Mar; 196():113897. PubMed ID: 33508764 [TBL] [Abstract][Full Text] [Related]
18. Protective effect of ginsenoside Rg3 on lung injury in diabetic rats. Wang H; Wu W; Wang G; Xu W; Zhang F; Wu B; Tian Y J Cell Biochem; 2019 Mar; 120(3):3323-3330. PubMed ID: 30362612 [TBL] [Abstract][Full Text] [Related]
19. Liquid chromatography/tandem mass spectrometry for pharmacokinetic studies of 20(R)-ginsenoside Rg3 in dog. Li K; Chen X; Xu J; Li X; Zhong D Rapid Commun Mass Spectrom; 2005; 19(6):813-7. PubMed ID: 15714599 [TBL] [Abstract][Full Text] [Related]
20. Plasma Pharmacokinetic Determination of Canagliflozin and Its Metabolites in a Type 2 Diabetic Rat Model by UPLC-MS/MS. Dong ST; Niu HM; Wu Y; Jiang JL; Li Y; Jiang KY; Wang X; Zhang MF; Han MF; Meng SN Molecules; 2018 May; 23(5):. PubMed ID: 29783787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]